Glyxambi 25mg/5mg Tablet is a combination medicine that helps control blood sugar levels. This medicine is used with diet and exercise to improve blood sugar control in adults with type 2 diabetes mellitus. It helps properly utilize insulin, thereby lowering the blood sugar level.
“Baidyanath (Jhansi) Yakuti Ras with Gold Pearl & Kesar” has been added to your cart. View cart
-10%

GLYTAS MF 10TAB
₹74.41 Original price was: ₹74.41.₹66.96Current price is: ₹66.96.

GLZ PLUS 15 TAB
₹168.60 Original price was: ₹168.60.₹151.74Current price is: ₹151.74.
GLYXAMBI 25/5 MG 10TAB
₹861.00 Original price was: ₹861.00.₹774.90Current price is: ₹774.90.
Glyxambi 25mg/5mg Tablet is a medicine that helps to control high blood glucose (sugar) levels. It helps get rid of extra glucose from your body through urine. Lowering blood glucose levels is an essential part of managing diabetes. If you can control the level, you will reduce the risk of getting any of the serious complications of diabetes, such as kidney damage, eye damage, nerve problems, and loss of limbs.
Category: Healthcare
Description
Reviews (0)
Be the first to review “GLYXAMBI 25/5 MG 10TAB” Cancel reply
Related products
Acnestar Facewash
Baidyanath (Jhansi) Swarna Bhasma with Gold
Baidyanath (Jhansi) Triphala Juice
Baidyanath Swarna Maha Yograj Guggulu Tablet
Baidyanath Vita EX Gold Women Capsule
Baidyanath Vita-Ex Gold Plus Capsule | For Strength & Stamina
Dabur Amritarishta Syrup
The key ingredient Amrutha is known for its dosha-balancing properties and may help nourish the body tissues particularly (rasa and rakta dhatus)
The presence of Dashamoola (group of 10 roots) and Trikatu (dry ginger – pepper – long pepper) in this formulation may act on inflammatory conditions and the digestive system respectively
The formulation may also help to provide comfort in case of associated body aches and swollen joints
Ingredients like Trikatu and Musta improve digestion while Indrayava, Parpataka etc. help ama dosha (accumulated toxins) from the body
Reviews
There are no reviews yet.